Akèy › Sklerodèm › South Carolina › Charleston
Etid klinik pou Sklerodèm nan Charleston, SC
4 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Medical University of South Carolina (MUSC), Charleston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Charleston, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Ap rekriteFaz 2
- aTyr Investigative Site, Charleston
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Chicago, IL10 etid
- Houston, TX9 etid
- Boston, MA7 etid
- Durham, NC7 etid
- Los Angeles, CA7 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- Dallas, TX5 etid
- Pittsburgh, PA5 etid
Lòt etid nan Charleston
- Depresyon19 etid
- Akidan serebavaskilè18 etid
- Ensifizyans kadyak18 etid
- Twoub Estres Post-Traumatik16 etid
- Kansè Poumon ki pa ti selil16 etid
- Kansè pwostat15 etid
- Maladi kadyovaskilè15 etid
- Karsinòm selil skuamèz tèt ak kou14 etid
- Kansè (tout kalite)14 etid
- Maladi Parkinson13 etid
- Maladi poumon entèstisyèl13 etid
- Kansè nan tete12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.